Lu AA21004: a novel potential treatment for mood disorders

被引：13
|
作者：
Moore, N. [1 ]
Bang-Andersen, B. [2 ]
Brennum, L. [2 ]
Fredriksen, K. [2 ]
Hogg, S. [2 ]
Mork, A. [2 ]
Stensbol, T. [2 ]
Zhong, H. [1 ]
Sanchez, C. [1 ]
Smith, D. [1 ]
机构：
[1] Lundbeck Res USA, Paramus, NJ USA
[2] H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70440-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [1] Discovery of Lu AA21004: A novel compound for the treatment of mood disorders
    Bang-Andersen, Benny
    Ruhland, Thomas
    Smith, Garrick
    Jorgensen, Morten
    Bjornholm, Berith
    Andersen, Kim
    Moltzen, Ejner K.
    Mork, Arne
    Brennum, Lise T.
    Jensen, Klaus G.
    Stensbol, Tine B.
    Hogg, Sandra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] In Vivo Effects of the Multi-Target Drug Lu AA21004: A Novel Potential Treatment for Mood Disorders
    Mork, Arne
    Brennum, Lise T.
    Fallon, Shaun M.
    Lassen, Anders B.
    Sanchez, Connie
    Stensbol, Tine B.
    Hogg, Sandra
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 73S - 73S
  • [3] The in vitro Proflie of Lu AA21004, a Novel Multi-Target Drug for the Treatment of Mood Disorders
    Stensbol, Tine B.
    Frederiksen, Kristen
    Zhong, Huailing
    Bang-Andersen, Benny
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 79S - 79S
  • [4] Pharmacological profile of Lu AA21004, a novel multi-target drug for the treatment of mood disorders
    Mork, A.
    Brennum, L. T.
    Fallon, S.
    Bisulco, S.
    Frederiksen, K.
    Bang-Andersen, B.
    Lassen, A. B.
    Zhong, H.
    Sanchez, C.
    Stensbol, T. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S439 - S439
  • [5] Lu AA21004, A Novel Multimodal Antidepressant
    Sanchez, Connie
    NEUROTHERAPEUTICS, 2012, 9 (03) : 681 - 682
  • [6] Investigation of the absorption profile of Lu AA21004
    Hojer, A. M.
    Sogaard, B.
    Areberg, J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 25 - 25
  • [7] Preclinical effects of Lu AA21004, a novel multimodal antidepressant
    Mork, A.
    Pehrson, A.
    Montezinho, L. C.
    Karlsson, J. J.
    Murphy, C. Trippodi
    Miller, S.
    Fischer, C. W.
    Liebenberg, N.
    Wegener, G.
    Sanchez, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S268 - S269
  • [8] RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS OF LU AA21004
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1114 - 1114
  • [9] Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
    Mork, A.
    Pehrson, A.
    Brennum, L. T.
    Nielsen, S. Moller
    Zhong, H.
    Lassen, A. B.
    Miller, S.
    Westrich, L.
    Boyle, N. J.
    Sanchez, C.
    Fischer, C. W.
    Liebenberg, N.
    Wegener, G.
    Bundgaard, C.
    Hogg, S.
    Bang-Andersen, B.
    Stensbol, T. Bryan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03): : 666 - 675
  • [10] Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
    Mork, Arne
    Montezinho, Liliana P.
    Miller, Silke
    Trippodi-Murphy, Crista
    Plath, Niels
    Li, Yan
    Gulinello, Maria
    Sanchez, Connie
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 : 41 - 50
12345